ACRoyer
MYPeters
MHeidbreder
They received one tablet of NLT (Revia, 50 mg) orally prior dialysis session. Further studies are necessary to identify those patients who respond favorably to the distinct pharmacotherapeutical interventions.Reprints and corresponding author: Falk Kiefer, MD, Department of Psychiatry, University Hospital of Hamburg, Martinistr 52, D-20246 Hamburg, Germany (e-mail: Submitted for publication October 17, 2001; final revision received May 6, 2002; accepted May 9, 2002.The University of Hamburg covered all costs for blinding the medication, production of placebos, laboratory analyses, and organization.The original medication was donated by DuPont, Bad Homburg, Germany (naltrexone), and Merck, Darmstadt, Germany (acamprosate).We thank A. Yassouridis, PhD, from the Max-Planck-Institute of Psychiatry, Munich, Germany, for biostatistical advice and statistical analysis of the data set.Samson
Volpicelli
JRUlm
CSellers
P Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. PM Does urge to drink predict relapse after treatment?
JK Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Craving
RAGordon
Oslin
CTran
T Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. Please enable it to take advantage of the complete set of features! MMoore
Whitworth
LDurbin
RE Neurobehavioral aspects of the pharmacotherapy of alcohol dependence. MWhelan
TIBrown
People on naltrexone should have their liver function tests monitored, both before taking the medication and periodically during their regimen.Some people may experience inflammation of the liver, known as hepatitis, with high doses of naltrexone. A, Craving assessed with the Obsessive Compulsive Drinking Scale (OCDS). CWhelan
JPHers
ALehert
FDaoust
JK Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
PDurlach
HFleischhacker
HR Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. DJHutchison